Related Experiment Video
Updated: Jul 12, 2026

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
Epinephrine facilitates neurogenic vasoconstriction in humans
J S Floras1, P E Aylward, R G Victor
1Department of Internal Medicine, University of Iowa College of Medicine, University of Iowa Hospitals and Clinics, Iowa City 52242.
Epinephrine and isoproterenol enhance neurogenic vasoconstriction in humans by facilitating norepinephrine release. This study provides the first hemodynamic evidence in humans for this effect, with epinephrine showing a sustained impact.
Area of Science:
- Cardiovascular Physiology
- Neuropharmacology
- Human Physiology
Background:
- Previous studies suggest epinephrine may facilitate neural release of norepinephrine (NE).
- Lack of human studies demonstrating the functional significance of epinephrine's action on neurogenic vasoconstriction.
Purpose of the Study:
- To determine if epinephrine facilitates neurogenic vasoconstriction in humans.
- To investigate the role of beta-receptor stimulation in this process.
Main Methods:
- Forearm vasoconstrictor responses to reflex stimulus (lower body negative pressure) and intra-arterial NE were measured before, during, and after epinephrine or isoproterenol infusion.
- Forearm blood flow and intra-arterial pressure were recorded in 23 healthy male volunteers.
- The ratio of vasoconstrictor responses to LBNP/NE served as an index of NE neural release.
Main Results:
- The LBNP/NE response ratio increased during epinephrine and isoproterenol infusions.
- Epinephrine significantly augmented the vasoconstrictor response to LBNP, while the response to NE tended to decrease.
- Isoproterenol did not alter vasoconstrictor responses to LBNP or NE.
Conclusions:
- Epinephrine, but not isoproterenol, is taken up by adrenergic terminals, released during reflex stimulation, and augments NE release.
- These findings provide the first hemodynamic evidence in humans that epinephrine and isoproterenol facilitate neurogenic vasoconstriction.
- The sustained effect of epinephrine suggests neural uptake and subsequent release are key mechanisms.
Related Concept Videos
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Sympathetic Activation

